10/31
07:36 am
vnda
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $18.00 price target on the stock.
Low
Report
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $18.00 price target on the stock.